Adding Liraglutide to High Dose Insulin: Breaking the Cycle

NCT01505673 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Obesity

Interventions

DRUG: Liraglutide
DRUG: Saline

Sponsor

Ildiko Lingvay

Collaborators

[object Object]